PEN Penumbra Inc

NYSE penumbrainc.com


$ 269.39 $ 4.62 (1.75 %)    

Friday, 07-Nov-2025 15:30:40 EST
QQQ $ 607.85 $ -0.48 (-0.08 %)
DIA $ 469.07 $ 0.86 (0.18 %)
SPY $ 669.17 $ 1.19 (0.18 %)
TLT $ 89.57 $ 0.21 (0.24 %)
GLD $ 367.81 $ -0.13 (-0.04 %)
$ 264.61
$ 264.36
$ 268.99 x 70
$ 269.55 x 30
$ 259.28 - $ 269.85
$ 221.26 - $ 310.00
1,111,215
na
10.36B
$ 0.88
$ 63.18
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 07-29-2025 06-30-2025 10-Q
3 04-23-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-23-2021 12-31-2020 10-K
21 11-02-2020 09-30-2020 10-Q
22 08-03-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-06-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 02-28-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-08-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-penumbra-raises-price-target-to-355

Canaccord Genuity analyst Jason Mills maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $350 to $355.

 stocks-rebound-eli-lilly-jumps-to-14-month-highs-whats-moving-markets-wednesday

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid soli...

 penumbra-presents-storm-pe-results-at-viva-2025-trial-data-shows-cavt-plus-anticoagulation-improves-functional-outcomes-than-anticoagulation-alone-in-pe-patients

The STORM-PE RCT data presented at the VIVA 2025 Conference showed PE patients treated with CAVT in combination with anticoagul...

 needham-reiterates-buy-on-penumbra-maintains-326-price-target

Needham analyst Mike Matson reiterates Penumbra (NYSE:PEN) with a Buy and maintains $326 price target.

 btig-reiterates-buy-on-penumbra-maintains-320-price-target

BTIG analyst Ryan Zimmerman reiterates Penumbra (NYSE:PEN) with a Buy and maintains $320 price target.

 truist-securities-maintains-buy-on-penumbra-lowers-price-target-to-300

Truist Securities analyst Richard Newitter maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $310 to...

 needham-upgrades-penumbra-to-buy-announces-326-price-target

Needham analyst Mike Matson upgrades Penumbra (NYSE:PEN) from Hold to Buy and announces $326 price target.

 evercore-isi-group-maintains-outperform-on-penumbra-lowers-price-target-to-285

Evercore ISI Group analyst Vijay Kumar maintains Penumbra (NYSE:PEN) with a Outperform and lowers the price target from $300...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION